[1] B. D'Autreaux, M. B. Toledano, "ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis," Nat. Rev. Mol. Cell Biol. 8(10), 813–824 (2007).
[2] C. Nathan, A. Cunningham-Bussel, "Beyond oxidative stress:An immunologist's guide to reactive oxygen species," Nat. Rev. Immunol. 13(5), 349–361 (2013).
[3] D. Trachootham, J. Alexandre, P. Huang, "Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach?," Nat. Rev. Drug Discov. 8(7), 579–591 (2009).
[4] K. J. Barnham, C. L. Masters, A. I. Bush, "Neurodegenerative diseases and oxidative stress," Nat. Rev. Drug. Discov. 3(3), 205–214 (2004).
[5] P. Fraisl, J. Aragones, P. Carmeliet, "Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease," Nat. Rev. Drug Discov. 8(2), 139–152 (2009).
[6] B. Yang, Y. Chen, J. Shi, "Reactive oxygen species (ROS)-based nanomedicine," Chem. Rev. 119(8), 4881–4985 (2019).
[7] E. A. Veal, A. M. Day, B. A. Morgan, "Hydrogen peroxide sensing and signaling," Mol. Cell 26(1), 1–14 (2007).
[8] T. J. Collier, N. M. Kanaan, J. H. Kordower, "Ageing as a primary risk factor for Parkinson's disease: Evidence from studies of non-human primates," Nat. Rev. Neurosci. 12(6), 359–366 (2011).
[9] M. J. Devine, H. Plun-Favreau, N. W. Wood, "Parkinson's disease and cancer: Two wars, one front," Nat. Rev. Cancer 11(11), 813–823 (2011).
[10] J. K. Andersen, "Oxidative stress in neurodegeneration: Cause or consequence?," Nat. Med. 10(S7), S18–S25 (2004).
[11] J. Blesa, I. Trigo-Damas, A. Quiroga-Varela, V. R. Jackson-Lewis, "Oxidative stress and Parkinson's disease," Front. Neuroanat. 9(91), 1–9 (2015).
[12] Y. Yang, Q. Zhao, W. Feng, F. Li, "Luminescent chemodosimeters for bioimaging," Chem. Rev. 113 (1), 192–270 (2013).
[13] J. L. Kolanowski, F. Liu, E. J. New, "Fluorescent probes for the simultaneous detection of multiple analytes in biology," Chem. Soc. Rev. 47(1), 195–208 (2018).
[14] K. Singh, A.M. Rotaru, A. A. Beharry, "Fluorescent chemosensors as future tools for cancer biology," ACS Chem. Biol. 13(7), 1785–1798 (2018).
[15] D. Wu, A. C. Sedgwick, T. Gunnlaugsson, E. U. Akkaya, J. Yoon, T. D. James, "Fluorescent chemosensors: The past, present and future," Chem. Soc. Rev. 46(23), 7105–7123 (2017).
[16] G. Zhang, A. Ding, Y. Zhang, L. Yang, L. Kong, X. Zhang, X. Tao, Y. Tian, J. Yang, "Schiff base modified α-cyanostilbene derivative with aggregation-induced emission enhancement characteristics for Hg2+ detection," Sens. Actuators B. Chem. 202, 209–216 (2014).
[17] G. Zhang, X. Zhang, Y. Zhang, H. Wang, L. Kong, Y. Tian, X. Tao, H. Bi, J. Yang, "Design of turn-on fluorescent probe for effective detection of Hg2+ by combination of AIEE-active fluorophore and binding site," Sens. Actuators B. Chem. 221, 730–739 (2015).
[18] M. Abo, Y. Urano, K. Hanaoka, T. Terai, T. Komatsu, T. Nagano, "Development of a highly sensitive fluorescence probe for hydrogen peroxide," J. Am. Chem. Soc. 133(27), 10629–10637 (2011).
[19] Z. Song, R. T. Kwok, D. Ding, H. Nie, J. W. Lam, B. Liu, B. Z. Tang, "An AIE-active fluorescence turn-on bioprobe mediated by hydrogen-bonding interaction for highly sensitive detection of hydrogen peroxide and glucose," Chem. Commun. 52(65), 10076–10079 (2016).
[20] H. Xiao, P. Li, S. Zhang, W. Zhang, W. Zhang, B. Tang, "Simultaneous fluorescence visualization of mitochondrial hydrogen peroxide and zinc ions in live cells and in vivo," Chem. Commun. 52(86), 12741–12744 (2016).
[21] X. Chen, F. Wang, J. Y. Hyun, T. Wei, J. Qiang, X. Ren, I. Shin, J. Yoon, "Recent progress in the development of fluorescent, luminescent and colorimetric probes for detection of reactive oxygen and nitrogen species," Chem. Soc. Rev. 45(10), 2976–3016 (2016).
[22] M. Ren, B. Deng, K. Zhou, X. Kong, J.-Y. Wang, W. Lin, "Single fluorescent probe for dual-imaging viscosity and H2O2 in mitochondria with different fluorescence signals in living cells," Anal. Chem. 89(1), 552–555 (2016).
[23] B. Dong, X. Song, X. Kong, C. Wang, Y. Tang, Y. Liu, W. Lin, "Simultaneous near-infrared and two-photon in vivo imaging of H2O2 using a ratiometric fluorescent probe based on the unique oxidative rearrangement of oxonium," Adv. Mater. 28(39), 8755–8759 (2016).
[24] H. Li, Q. Yao, J. Fan, J. Du, J. Wang, X. Peng, "A two-photon NIR-to-NIR fluorescent probe for imaging hydrogen peroxide in living cells," Biosens. Bioelectron. 94, 536–543 (2017).
[25] M. G. Savelieff, G. Nam, J. Kang, H. J. Lee, M. Lee, M. H. Lim, "Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis in the last decade," Chem. Rev. 119(2), 1221–1322 (2019).
[26] L. Qian, L. Li, S. Q. Yao, "Two-photon small molecule enzymatic probes," Acc. Chem. Res. 49(4), 626–634 (2016).
[27] L. Wang, W. Du, Z. Hu, K. Uvdal, L. Li, W. Huang, "Hybrid rhodamine fluorophores in the visible/NIR region for biological imaging," Angew. Chem. Int. Ed. 58, 14026–14043 (2019).
[28] G. Zhang, Y. Zhao, B. Peng, Z. Li, C. Xu, Y. Liu, C. Zhang, N. H. Voelcker, L. Li, W. Huang, "A fluorogenic probe based on chelation-hydrolysisenhancement mechanism for visualizing Zn2+ in Parkinson's disease models," J. Mater. Chem. B 7(14), 2252–2260 (2019).
[29] G. Zhang, Y. Ni, D. Zhang, H. Li, N. Wang, C. Yu, L. Li, W. Huang, "Rational design of NIR fluorescence probes for sensitive detection of viscosity in living cells," Spectrochim. Acta. A Mol. Biomol. Spectrosc. 214, 339–347 (2019).
[30] X. Qiu, C. Xin, W. Qin, Z. Li, D. Zhang, G. Zhang, B. Peng, X. Han, C. Yu, L. Li, W. Huang, "A novel pyrimidine based deep-red fluorogenic probe for detecting hydrogen peroxide in Parkinson's disease models," Talanta. 199, 628–633 (2019).
[31] X. Qin, C. Yu, J. Wei, L. Li, C. Zhang, Q. Wu, J. Liu, S. Q. Yao, W. Huang, "Rational design of nanocarriers for intracellular protein delivery," Adv. Mater. 31(46), 1902791 (2019).
[32] H. Li, C. Xin, G. Zhang, X. Han, W. Qin, C. W. Zhang, C. Yu, S. Jing, L. Li, W. Huang, "A mitochondria-targeted two-photon fluorogenic probe for the dual-imaging of viscosity and H2O2 levels in Parkinson's disease models," J. Mater. Chem. B 7(27), 4243–4251 (2019).
[33] Y. Liu, L. Bai, Y. Li, Y. Ni, C. Xin, C. Zhang, J. Liu, Z. Liu, L. Li, W. Huang, "Visualizing hydrogen peroxide in Parkinson's disease models via a ratiometric NIR fluorogenic probe," Sens. Actuators B: Chem. 279, 38–43 (2019).
[34] T. W. Harris, "WormBase: A multi-species resource for nematode biology and genomics," Nucleic Acids Res. 32(90001), 411D–417 (2004).
[35] M. Markaki, N. Tavernarakis, "Modeling human diseases in Caenorhabditis elegans," Biotechnol. J. 5 (12), 1261–1276 (2010).
[36] L. Li, C. W. Zhang, G. Y. Chen, B. Zhu, C. Chai, Q. H. Xu, E. K. Tan, Q. Zhu, K. L. Lim, S. Q. Yao, "A sensitive two-photon probe to selectively detect monoamine oxidase B activity in Parkinson's disease models," Nat. Commun. 5, 3276 (2014).
[37] C. W. Zhang, H. B. Adeline, B. H. Chai, E. T. Hong, C. H. Ng, K. L. Lim, "Pharmacological or genetic activation of Hsp70 protects against loss of parkin function," Neurodegener Dis. 16(5–6), 304–316 (2016).